Optimizing Therapy for Patients with Acute and Chronic Graft-Versus-Host Disease (GvHD) - Episode 1

Understanding Chronic and Acute Graft-Versus-Host Disease Presentation and Diagnosis

June 23, 2023

Michael R. Bishop, MD, University of Chicago, Hannah Choe, MD, Doris M. Ponce, MD, Bart L. Scott, MD

Moderator Michael Bishop, MD introduces expert panelists and leads an overview of Graft-Versus-Host Disease, covering the differences between chronic and acute conditions, how GvHD is typically diagnosed, and GvHD risk assessment.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

Now Viewing

EP. 1: Understanding Chronic and Acute Graft-Versus-Host Disease Presentation and Diagnosis

EP. 2: Improving Patient Outcomes: Prophylactic Options in Graft-Versus-Host Disease

EP. 3: Optimal First-Line Treatment Approaches for Acute GvHD

EP. 4: Treatment Options in Steroid-Refractory Acute GvHD

EP. 5: Enhancing Patient Care in Acute GvHD: Supportive Measures

EP. 6: Advancements and Promising Directions in Acute GvHD

EP. 7: Establishing Treatment Objectives for Chronic GvHD: First-Line Strategies

EP. 8: A Comprehensive Look at Initial Treatment Options for Chronic GvHD

EP. 9: Data-Driven Treatment Selection for Patients with Chronic GvHD

EP. 10: Remote Patient Monitoring and Supportive Care Measures in Chronic GvHD

EP. 11: The Future of Chronic GvHD Treatment

EP. 12: Dr Rifkin on the Role of Belantamab Mafodotin in Relapsed/Refractory Multiple Myeloma